How Can Hospital Bed Design Impact Care?

 

There’s no doubt about it, patient care is a priority across the healthcare system. And while there are many aspects to patient care, there are some internal features in hospitals that are lacking: beds. We have the technology to improve the patient experience and patient outcomes through improving their beds, but not every hospital is up to speed.

How is one company changing the game, or the bed, to improve patient outcomes? On the latest episode of I Don’t Care with Kevin Stevenson, guest Shane Jones, Account Executive at Linet Americas, discusses Linet America’s foundational values, how a hospital bed can have an impact on patient care, and his own personal journey in learning more about Down syndrome.

As the number one largest healthcare bed manufacturer in the world, Linet Americas has exported over 1 million beds to over 120 countries. While they started as a start-up created by a biomedical engineer who just wanted to help his local community, they are growing rapidly, particularly in the U.S.

Jones noted the beds are, “…Also very effective in how we provide care. They’re designed for nurses, by nurses…and it all translates into better care and better outcomes at the end of the day in terms of safe-patient handling, fall-prevention, care, all those things that we’re all focused on.”

Stevenson and Jones discuss…

● How a hospital bed can be a tool for more effective patient care

● How patient data collection can be made easier through sensor-lined beds and the SafetyPort program

● The importance of raising awareness about Down syndrome and the journey of navigating that experience

“The World Down syndrome Day website had all these resources as well…But I think the main thing that I want to just get out to people is a few different things: One being just being very accepting and inclusive of others, being kind…just being educated…you can learn about Down syndrome, you know, what comes along with it…They’re normal kids at the end of the day, they just have an extra 21st chromosome,” said Jones.

Jones has nearly 10 years of experience in the healthcare industry. Prior to his role with Linet Americas, Jones worked as a Strategic Planner for UT Southwestern Medical Center and as a Data Analyst for Wise Health System. He is a graduate of Texas Tech University with a Bachelor of Science and holds his MHA from the UNT Health Science Center.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More